Wave Life Sciences, Inc. (WVE) KPIs and segments
Close on Nov 17, 2026Market cap $560.13MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Wave Life Sciences's business
Wave Life Sciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Singapore($M) | -6.04 | -4.20 | -7.44 | -8.71 | -10.8 | -9.93 | -5.93 | -14.5 | -76.7 | -53.4 | -16.5 | -4.54 | |
Rest Of World($M) | -198 | -92.8 | -50.7 | -152 | -112 | -141 | -188 | -132 | -24.4 | -1.40 | -2.62 | -0.60 | |
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-02-26.
See a number that looks wrong?